Full Text View
Tabular View
No Study Results Posted
Related Studies
Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection
This study has been terminated.
Study NCT00006630   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: December 6, 2000   Last Updated: September 8, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Communicable Diseases
Additional conditions recognized in this trial
Infection
Vaccinia
More general conditions related to this trial
DNA Virus Infections
Poxviridae Infections
Virus Diseases
Interventions listed in this trial
Vaccinia Immune Globulin (Human)
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services